Sinocelltech
Beijing
About Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines. It has developed platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. The company is driven by a mission to make life-saving biological medicines available to ordinary people with ever-improving process and manufacturing technologies to drive down the cost of product development and production.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $29.0M
- Funding stage: IPO
- Last round: Series A (May 2017)
- Ticker: sse:688520
- Website: sinocelltech.com
- Phone: 86-10-5862-8288
Industries & Categories
Biotechnology, Health Care, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sinocelltech-100585 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.